Aberdeen Wealth Management LLC

Position in NVAX — Novavax Inc

CIK 1802654 LAKE BLUFF, IL

Position in NVAX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$6,217

New position

Shares Held

660

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#205

of 263 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Aberdeen Wealth Management LLC holds $380,485 across 6 Biotechnology names. NVAX ranks #5 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	1,950	$136,558
2	CRSP	CRISPR Therapeutics AG	2,110	$115,077
3	BNTX	BioNTech SE	880	$81,884
4	REGN	Regeneron Pharmaceuticals, Inc.	65	$40,530
5	NVAX	Novavax Inc This page	660	$6,217
6	INO	Inovio Pharmaceuticals, Inc.	200	$219

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,217	660	—	Shares	Sole	2026-08-13
No filing history on record for this holder in this stock.